Cargando…
Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
Molecular tumor biomarkers hold considerable promise for accurately predicting colorectal cancer (CRC) recurrence and progression. Prokineticin 2 (PROK2) may be associated with angiogenesis and tumor formation in some malignant tumors. However, its prognostic value remains unknown. We focused on the...
Autores principales: | Yoshida, Yu, Goi, Takanori, Kurebayashi, Hidetaka, Morikawa, Mitsuhiro, Hirono, Yasuo, Katayama, Kanji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059027/ https://www.ncbi.nlm.nih.gov/pubmed/30046389 http://dx.doi.org/10.18632/oncotarget.25706 |
Ejemplares similares
-
Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015) -
Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study
por: Tagai, Noriyuki, et al.
Publicado: (2021) -
Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
por: Kurebayashi, Hidetaka, et al.
Publicado: (2015) -
Large-cell neuroendocrine carcinoma of the common bile duct: a case report and a review of literature
por: Murakami, Makoto, et al.
Publicado: (2016) -
Stage IV anal canal squamous cell carcinoma with long-term survival: a case report
por: Sawai, Katsuji, et al.
Publicado: (2022)